TLDR
- Krane Funds Advisors increased its AMD position by 72.7% during Q4, expanding holdings to 11,306 shares valued at approximately $2.42 million.
- Advanced Micro Devices delivered Q1 EPS of $1.37, surpassing consensus by $0.08, while revenue jumped 37.8% year-over-year to $10.25 billion.
- Goldman Sachs elevated AMD to Buy from Neutral, increasing its price target from $240 to $450; TD Cowen pushed its target to $600.
- Shares opened at $466.38, significantly above the 50-day moving average of $358.36, with Street consensus averaging $419.86.
- Company insiders offloaded $119.5 million in shares over the last 90 days, while semiconductor stocks faced headwinds following Broadcom’s disappointing AI forecast.
Advanced Micro Devices has emerged as a standout narrative in the chip sector recently. Robust quarterly results, a series of Street upgrades, and accelerating institutional accumulation have driven shares considerably higher than recent trading ranges — though volatility remains a constant companion.
Advanced Micro Devices, Inc., AMD
Shares opened Monday at $466.38, representing a substantial premium to the 50-day moving average of $358.36 and well beyond the 200-day moving average of $265.16. The 52-week trading range spans from $115.06 to $546.44, underscoring the dramatic swings investors have navigated.
The primary driver behind recent optimism was AMD’s first-quarter earnings release. The chipmaker delivered earnings of $1.37 per share, exceeding Wall Street’s $1.29 estimate. Revenue totaled $10.25 billion, topping projections of $9.90 billion while marking a 37.8% increase compared to the prior-year period.
Performance like that typically captures institutional attention.
Wave of Street Upgrades
Goldman Sachs shifted AMD to Buy from Neutral on May 6, simultaneously raising its price objective from $240 to $450. Sanford C. Bernstein followed suit, elevating the stock from Market Perform to Outperform while boosting its target from $265 to $525.
TD Cowen pushed even higher, establishing a $600 price target on June 1 while reaffirming its Buy recommendation. JPMorgan maintained its Neutral position but still increased its target from $270 to $385. Barclays maintains a $665 price target, citing expanding CPU demand driven by accelerating AI infrastructure buildouts.
Street consensus currently registers as Moderate Buy, with an average price objective of $419.86. Interestingly, that figure trails the current trading price, suggesting the recent rally has outpaced analyst expectations.
Among institutional players, Krane Funds Advisors expanded its AMD holdings by 72.7% in Q4, bringing its stake to 11,306 shares worth roughly $2.42 million. Vanguard maintains the largest institutional position with more than 158 million shares valued at approximately $33.9 billion. Norges Bank initiated a fresh position valued at around $4.9 billion during the fourth quarter.
Institutional investors and hedge funds collectively control 71.34% of AMD’s outstanding shares.
Executive Selling and Market Pressures
Not all signals point upward. Corporate insiders divested $119.5 million in AMD shares over the past three months. EVP Paul Darren Grasby sold 24,376 shares at $444.39 apiece on May 8. EVP Mark D. Papermaster offloaded 31,320 shares at $350.00 on April 24 through a pre-established 10b5-1 plan.
On the broader market front, AMD experienced pressure after Broadcom’s quarterly results fell short of investor expectations around AI revenue growth. That disappointment sent semiconductor stocks lower and rekindled valuation debates surrounding AMD, particularly given its elevated price-to-earnings ratio of 152.91.
TSMC has also indicated that AI chip supply constraints will persist for years, which supports long-term demand dynamics but highlights ongoing production bottlenecks across the industry.
Wall Street analysts project full-year earnings of $6.20 per share for AMD.





